Find Clinical Trial
A clinical study to test the safety and the efficacy of a single-pill combination of 2 antihypertensive and 1 lipid-lowering drug in patients already well treated with the concomitant administration of the same three drugs on separate tablets
← Back
| Study Phase |
Phase 3 |
| Therapeutic Area |
Cardiovascular Diseases |
| Indication | Dyslipidemia, Hypertension |
| Sponsor | Institut de Recherches Internationales Servier (I.R.I.S) |
| Active substance/ Medical device |
AMLODIPINE, ATORVASTATIN, PERINDOPRIL ARGININE, |
| Active Substance Code | S005153 |
| Protocol Code | CL3-05153-008 |
| ISRCTN Code | ISRCTN27159806 |
Documents and links
| Results summary | READ MORE  |
Quote
| "An open-label study to assess the safety and efficacy of atorvastatin/amlodipine/perindopril fixed-dose combination in adult patients, following four weeks of adequate treatment with atorvastatin, amlodipine and perindopril given concurrently. Hoa et al., HCMC Cardiology Association Journal, Oct 2018" |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility
